Why the study?
Does intravenous atrial natriuretic peptide (ANP) reduce infarct size and improve left ventricular function in patients with acute myocardial infarction undergoing PCI?
Does intravenous atrial natriuretic peptide (ANP) reduce infarct size and improve left ventricular function in patients with acute myocardial infarction undergoing PCI?
No takes yet. Share an insight, caveat, or question.
The J-WIND-ANP trial is designed to evaluate whether intravenous ANP as an adjunct to PCI reduces infarct size and improves LV function in AMI patients.
Asakura et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: